Kraft Davis & Associates LLC Makes New $277,000 Investment in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Kraft Davis & Associates LLC acquired a new stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 3,618 shares of the company’s stock, valued at approximately $277,000. Kraft Davis & Associates LLC owned about 0.10% of Invesco Pharmaceuticals ETF as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Morgan Stanley raised its holdings in Invesco Pharmaceuticals ETF by 12.9% in the 4th quarter. Morgan Stanley now owns 158,831 shares of the company’s stock valued at $12,484,000 after acquiring an additional 18,173 shares during the period. Bank of America Corp DE lifted its holdings in Invesco Pharmaceuticals ETF by 78.4% during the 4th quarter. Bank of America Corp DE now owns 97,302 shares of the company’s stock worth $7,648,000 after purchasing an additional 42,755 shares during the last quarter. UBS Group AG lifted its holdings in Invesco Pharmaceuticals ETF by 132.2% during the 3rd quarter. UBS Group AG now owns 92,123 shares of the company’s stock worth $6,667,000 after purchasing an additional 52,455 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Invesco Pharmaceuticals ETF by 102.3% in the 2nd quarter. Wells Fargo & Company MN now owns 61,645 shares of the company’s stock valued at $4,662,000 after purchasing an additional 31,171 shares during the period. Finally, International Assets Investment Management LLC acquired a new position in Invesco Pharmaceuticals ETF in the 4th quarter valued at $4,633,000.

Invesco Pharmaceuticals ETF Trading Up 1.0 %

PJP stock traded up $0.73 during trading hours on Friday, hitting $76.06. 11,635 shares of the stock were exchanged, compared to its average volume of 26,737. Invesco Pharmaceuticals ETF has a 12 month low of $67.75 and a 12 month high of $80.65. The firm has a market capitalization of $266.96 million, a P/E ratio of 20.52 and a beta of 0.64. The company has a 50-day simple moving average of $77.96 and a two-hundred day simple moving average of $74.82.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.